Literature DB >> 24375252

The co-expression of telomerase and ALT pathway in human breast cancer tissues.

Bin Xu1, Min Peng, Qibin Song.   

Abstract

Recently, telomerase-targeted therapy was studied intensively; however, many studies have verified the existence of alternative lengthening mechanisms of telomeres in vitro. In the present work, we explored the expression characteristic of the two kinds of telomere-prolonging mechanisms in the breast cancer tissues per se. Furthermore, we studied the relationship between Her-2 expression and ALT pathway. Ninety samples of breast cancer tissues were examined in this research. RT-PCR was used for the detection of the expression of human telomerase reverse transcriptase (hTERT); IHC was used for the detection of the expression of promyelocytic leukemia body (PML) bodies; the co-expression of PML bodies and hTERT was detected using the QDs-based immunofluorescence. The co-expression of PML body and hTERT was found in the same cell in breast cancer tissues, and ten samples expressed neither PML bodies nor hTERT. Additionally, the expression of PML bodies and Her-2 was statistically co-related (P = 0.047). The two kinds of mechanisms of telomere extension can co-exist in the same cell in beast cancer tissues, and there may be other mechanisms of telomere extension functioning in human breast carcinoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24375252     DOI: 10.1007/s13277-013-1534-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  20 in total

Review 1.  PML nuclear bodies.

Authors:  Valérie Lallemand-Breitenbach; Hugues de Thé
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-21       Impact factor: 10.005

2.  Telomerase- and Rad52-independent immortalization of budding yeast by an inherited-long-telomere pathway of telomeric repeat amplification.

Authors:  Nathalie Grandin; Michel Charbonneau
Journal:  Mol Cell Biol       Date:  2008-12-01       Impact factor: 4.272

3.  Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.

Authors:  J V Grobelny; M Kulp-McEliece; D Broccoli
Journal:  Hum Mol Genet       Date:  2001-09-01       Impact factor: 6.150

4.  Incidence and mortality of breast cancer in China, 2008.

Authors:  Wan-Qing Chen; Rong-Shou Zheng; Hong-Mei Zeng; Si-Wei Zhang; Guang-Lin Li; Liang-You Wu; Jie He
Journal:  Thorac Cancer       Date:  2013-02       Impact factor: 3.500

5.  A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.

Authors:  Jeremy D Henson; Jonathan A Hannay; Stanley W McCarthy; Janice A Royds; Thomas R Yeager; Robert A Robinson; Stephen B Wharton; David A Jellinek; Susan M Arbuckle; Jinyoung Yoo; Bruce G Robinson; Diana L Learoyd; Paul D Stalley; S Fiona Bonar; Dihua Yu; Raphael E Pollock; Roger R Reddel
Journal:  Clin Cancer Res       Date:  2005-01-01       Impact factor: 12.531

Review 6.  Alternative lengthening of telomeres in human cells.

Authors:  R R Reddel; T M Bryan; L M Colgin; K T Perrem; T R Yeager
Journal:  Radiat Res       Date:  2001-01       Impact factor: 2.841

7.  SUMmOning Daxx-mediated repression.

Authors:  Debaditya Mukhopadhyay; Michael J Matunis
Journal:  Mol Cell       Date:  2011-04-08       Impact factor: 17.970

8.  The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression.

Authors:  Andrea Proctor Subhawong; Christopher M Heaphy; Pedram Argani; Yuko Konishi; Nina Kouprina; Hind Nassar; Russell Vang; Alan K Meeker
Journal:  Mod Pathol       Date:  2009-09-04       Impact factor: 7.842

Review 9.  The disparity between human cell senescence in vitro and lifelong replication in vivo.

Authors:  Harry Rubin
Journal:  Nat Biotechnol       Date:  2002-07       Impact factor: 54.908

10.  Telomeric DNA mediates de novo PML body formation.

Authors:  Anneke K Brouwer; Joost Schimmel; Joop C A G Wiegant; Alfred C O Vertegaal; Hans J Tanke; Roeland W Dirks
Journal:  Mol Biol Cell       Date:  2009-09-30       Impact factor: 4.138

View more
  8 in total

1.  Alternative Lengthening of Telomeres (ALT) and Telomerase Reverse Transcriptase Promoter Methylation in Recurrent Adult and Primary Pediatric Pituitary Neuroendocrine Tumors.

Authors:  Hiba Alzoubi; Simone Minasi; Francesca Gianno; Manila Antonelli; Francesca Belardinilli; Felice Giangaspero; Marie-Lise Jaffrain-Rea; Francesca Romana Buttarelli
Journal:  Endocr Pathol       Date:  2022-01-06       Impact factor: 3.943

2.  TGS1 mediates 2,2,7-trimethyl guanosine capping of the human telomerase RNA to direct telomerase dependent telomere maintenance.

Authors:  Valentina Buemi; Odessa Schillaci; Mariangela Santorsola; Deborah Bonazza; Pamela Veneziano Broccia; Annie Zappone; Cristina Bottin; Giulia Dell'Omo; Sylvie Kengne; Stefano Cacchione; Grazia Daniela Raffa; Silvano Piazza; Fabrizio d'Adda di Fagagna; Roberta Benetti; Maurizio Cortale; Fabrizio Zanconati; Giannino Del Sal; Stefan Schoeftner
Journal:  Nat Commun       Date:  2022-04-28       Impact factor: 17.694

3.  SLX4IP Promotes Telomere Maintenance in Androgen Receptor-Independent Castration-Resistant Prostate Cancer through ALT-like Telomeric PML Localization.

Authors:  Tawna L Mangosh; Wisam N Awadallah; Magdalena M Grabowska; Derek J Taylor
Journal:  Mol Cancer Res       Date:  2020-11-13       Impact factor: 6.333

Review 4.  Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).

Authors:  Marco De Vitis; Francesco Berardinelli; Antonella Sgura
Journal:  Int J Mol Sci       Date:  2018-02-18       Impact factor: 5.923

5.  The Transition between Telomerase and ALT Mechanisms in Hodgkin Lymphoma and Its Predictive Value in Clinical Outcomes.

Authors:  Radhia M'kacher; Corina Cuceu; Mustafa Al Jawhari; Luc Morat; Monika Frenzel; Grace Shim; Aude Lenain; William M Hempel; Steffen Junker; Theodore Girinsky; Bruno Colicchio; Alain Dieterlen; Leonhard Heidingsfelder; Claire Borie; Noufissa Oudrhiri; Annelise Bennaceur-Griscelli; Olivier Moralès; Sarah Renaud; Zoé Van de Wyngaert; Eric Jeandidier; Nadira Delhem; Patrice Carde
Journal:  Cancers (Basel)       Date:  2018-05-30       Impact factor: 6.639

6.  Telomere Dysfunction Is Associated with Altered DNA Organization in Trichoplein/Tchp/Mitostatin (TpMs) Depleted Cells.

Authors:  Angela Lauriola; Pierpaola Davalli; Gaetano Marverti; Andrea Caporali; Sabine Mai; Domenico D'Arca
Journal:  Biomedicines       Date:  2022-07-05

Review 7.  Alternative Lengthening of Telomeres (ALT) in Tumors and Pluripotent Stem Cells.

Authors:  Shuang Zhao; Feng Wang; Lin Liu
Journal:  Genes (Basel)       Date:  2019-12-10       Impact factor: 4.096

Review 8.  ALT Positivity in Human Cancers: Prevalence and Clinical Insights.

Authors:  Danny MacKenzie; Andrea K Watters; Julie T To; Melody W Young; Jonathan Muratori; Marni H Wilkoff; Rita G Abraham; Maria M Plummer; Dong Zhang
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.